Le Lézard
Classified in: Health, Business
Subjects: CCA, FVT

Aflac Incorporated to Release Third Quarter Results on October 25, 2017


COLUMBUS, Ga., Oct. 18, 2017 /PRNewswire/ -- Aflac Incorporated (NYSE: AFL) announced today that it will release third quarter financial results after the market closes on October 25, 2017.

In conjunction with the earnings release, Aflac Incorporated will webcast a conference call scheduled for 9:00 a.m. (EDT) on October 26, 2017. During the teleconference, the company will discuss third quarter results and its outlook. The following executives will be available to answer questions: Aflac Incorporated Chairman and Chief Executive Officer Daniel P. Amos; Aflac Incorporated President Kriss Cloninger III; Executive Vice President and Chief Financial Officer of Aflac Incorporated Frederick J. Crawford; President and Chief Operating Officer of Aflac Japan Masatoshi Koide; President of Aflac U.S. Teresa L. White; Executive Vice President and Global Chief Investment Officer Eric M. Kirsch and Executive Vice President; Global Chief Risk Officer and Chief Actuary J. Todd Daniels.

To listen to the third quarter conference call, visit aflac.com/investors. Registration is required, so please allow five to seven minutes to sign up prior to the scheduled start time. 

About Aflac
When a policyholder gets sick or hurt, Aflac pays cash benefits fast. For more than six decades, Aflac insurance policies have given policyholders the opportunity to focus on recovery, not financial stress. In the United States, Aflac is the leader in voluntary insurance sales at the worksite. Through its trailblazing One Day PaySM initiative, Aflac U.S. can receive, process, approve and disburse payment for eligible claims in one business day. In Japan, Aflac is the leading provider of medical and cancer insurance and insures 1 in 4 households. Aflac insurance products help provide protection to more than 50 million people worldwide. For 11 consecutive years, Aflac has been recognized by Ethisphere as one of the World's Most Ethical Companies. In 2017, Fortune magazine recognized Aflac as one of the 100 Best Companies to Work for in America for the 19th consecutive year and in 2017 included Aflac on its list of Most Admired Companies for the 16th time. Aflac Incorporated is a Fortune 500 company listed on the New York Stock Exchange under the symbol AFL. To find out more about Aflac and One Day PaySM, visit aflac.com or aflac.com/espanol.

Aflac Logo. (PRNewsFoto/Aflac)

Analyst and investor contact ? David A. Young, 706.596.3264 or 800.235.2667, FAX: 706.324.6330, or [email protected]

Media contact ? Catherine H. Blades, 706.596.3014 FAX: 706.320.2288 or [email protected]

SOURCE Aflac Incorporated


These press releases may also interest you

at 05:29
SmartCella Holding AB today announces that Dr Ricardo Baptista has been appointed Chief Technology Officer (CTO) and Head of Procella. Ricardo is an experienced Biochemical Engineer with almost 20-years of global experience in the medical...

at 05:15
Every year in Quebec, more than 2,000 young people leave the care of the Director of Youth Protection (DYP) as they approach the age of majority. For youth under the care of the DYP, turning 18 means having to become independent quickly, with little...

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...

at 02:32
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...



News published on and distributed by: